webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate

  CAS No.: 1232769-29-7   Cat No.: BADC-00437   Purity: ≥98% 4.5  

2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1 -oate is an innovative biomedical chemical. Utilizing its unique chemical composition, it actively disrupts malignant molecular pathways to prevent tumor proliferation. Its superb targeted delivery capabilities act as a catalyst, amplifying the therapeutic effects and propelling it to the forefront of promising targeted cancer treatment candidates.

2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate

Structure of 1232769-29-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C22H30N2O12
Molecular Weight
514.48
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate;
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCC(=O)N2C(=O)C=CC2=O
InChI
InChI=1S/C22H30N2O12/c25-17-1-2-18(26)23(17)19(27)5-7-31-9-11-33-13-15-35-16-14-34-12-10-32-8-6-22(30)36-24-20(28)3-4-21(24)29/h1-2H,3-16H2
InChIKey
NDZFOMRDWBBFNL-UHFFFAOYSA-N
Appearance
Soild powder
Shipping
Room temperature

2,5-Dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate (abbreviated as PDP) is crucial in the field of drug delivery systems. Its unique chemical structure allows it to form stable conjugates with various drug molecules, enhancing their solubility and bioavailability. This characteristic is especially beneficial for poorly water-soluble drugs, making PDP an invaluable component in formulating new pharmaceutical compounds. It provides a stable and biodegradable linkage that can be cleaved under physiological conditions, releasing the active pharmaceutical ingredient precisely where and when it is needed. Consequently, PDP is likely to play a significant role in the design of next-generation drug delivery systems aimed at improving therapeutic outcomes while minimizing side effects.

In the realm of biomaterials, PDP serves as a cross-linking agent in the synthesis of hydrogels. Hydrogels are widely used in various medical applications such as wound dressings, tissue engineering, and drug delivery matrices. The cross-linking properties of PDP enable the formation of hydrogels with desirable mechanical strength and stability. Moreover, the biodegradability of the cross-linked structure ensures that these hydrogels can be safely absorbed or excreted by the body. This makes PDP an essential component in developing biocompatible and environmentally friendly hydrogels that can be customized for specific medical needs. The potential for creating smart hydrogels that respond to environmental stimuli such as pH and temperature further expands the versatility of PDP-based biomaterials.

PDP is also extensively utilized in peptide synthesis. The compound’s active ester group readily reacts with amine groups, facilitating the formation of peptide bonds. This has made PDP a popular reagent in the laboratory for synthesizing complex peptides and proteins. Its use in solid-phase peptide synthesis (SPPS) allows for the efficient and sequential addition of amino acids, making the process more practical and streamlined. Additionally, the high yield and purity of peptides synthesized using PDP make it an indispensable tool in both research and industrial settings. As the demand for synthetic peptides in pharmaceuticals, diagnostics, and as research tools continues to grow, the importance of PDP in this area cannot be overstated.

Finally, PDP finds applications in the field of organic synthesis, particularly in the modification of polymers. This compound can introduce functional groups onto polymer chains, thereby altering their chemical and physical properties. Such modifications are useful in creating specialty polymers with tailor-made characteristics for specific applications, such as in coatings, adhesives, and biomedical devices. By facilitating the introduction of reactive sites within the polymer backbone, PDP enables the subsequent attachment of other functional molecules, enhancing the material’s functionality and usability. The versatility of PDP in polymer chemistry paves the way for innovative solutions in materials science, contributing to advancements in various industrial sectors.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Azido-PEG5-Ala-Ala-Asn-PAB | Propargyl-PEG1-SS-PEG1-propargyl | 2,5-dioxopyrrolidin-1-yl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | 3-beta-iodo-Imperialine | Spliceostatin B | 2,5-dioxopyrrolidin-1-yl 3-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)oxy)propanoate | CHO-Ph-CONH-PEG3-NHS ester | CHO-Ph-CONH-PEG1-NHS ester | Propargyl-O-C1-amido-PEG2-C2-NHS ester | 4-Formyl-N-(2-(p-Tolyloxy)ethyl)benzamide | 2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate
Send Inquiry
Verification code
Inquiry Basket